STAT3 and rheumatoid arthritis: The JAK2/STAT3 pathway inhibitor, AG490, has been shown to influence P-gp expression levels in the above experiments; thus, we further investigated the effect of AG490 on MTX and MTX + 4-HC activity in RA-FLSs (Figure 2(a)).